(Total Views: 85)
Posted On: 06/24/2017 3:52:23 PM
Post# of 23078
Oclaro, Inc. (NASDAQ:OCLR) is now covered by analysts at DA Davidson on Thursday. They set a "buy" rating and a $14.00 price target on the stock. 39.9% upside from the previous close of $10.01.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) had its price target raised by analysts at Piper Jaffray Companies from $446.00 to $557.00 on Tuesday. They now have an "overweight" rating on the stock. 7.7% upside from the previous close of $517.33.
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSE:VRX) was given a new $19.00 price target on by analysts at Royal Bank Of Canada on Monday. They now have a "sector perform" rating on the stock. 20.3% upside from the previous close of $15.80.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) had its price target raised by analysts at Piper Jaffray Companies from $446.00 to $557.00 on Tuesday. They now have an "overweight" rating on the stock. 7.7% upside from the previous close of $517.33.
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSE:VRX) was given a new $19.00 price target on by analysts at Royal Bank Of Canada on Monday. They now have a "sector perform" rating on the stock. 20.3% upside from the previous close of $15.80.
(1)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280
